Improving patients' outcomes after osteoporotic fractures

International Journal of Clinical Rheumatology

Volumn 7, Issue 1, 2012, Pages 109-124

  Dimitriou, Rozalia ^a   Calori, Giorgio Maria ^b   Giannoudis, Peter V ^a  

^a UNIVERSITY OF LEEDS   (United Kingdom)

^b UNIVERSITY OF MILAN   (Italy)

Author keywords

fragility fractures; osteoporosis; osteoporotic fractures; outcome; secondary prevention

Indexed keywords

ALENDRONIC ACID; BISPHOSPHONIC ACID DERIVATIVE; DENOSUMAB; IBANDRONIC ACID; PARATHYROID HORMONE[1-34]; RISEDRONIC ACID; VITAMIN D; ZOLEDRONIC ACID;

ACCIDENT PREVENTION; CALCIUM INTAKE; CONSERVATIVE TREATMENT; DELIRIUM; DIET SUPPLEMENTATION; DISEASE ASSOCIATION; DRUG EFFICACY; DRUG SAFETY; FRACTURE FIXATION; FRAGILITY FRACTURE; FUNCTIONAL ASSESSMENT; GASTROINTESTINAL IRRITATION; HEALTH CARE QUALITY; HIP FRACTURE; HUMAN; JAW OSTEONECROSIS; LIFESTYLE MODIFICATION; METABOLIC BONE DISEASE; OSTEOPOROSIS; OUTCOME ASSESSMENT; PATIENT ASSESSMENT; PATIENT COMPLIANCE; PELVIS FRACTURE; PERCUTANEOUS VERTEBROPLASTY; PHYSICAL ACTIVITY; POSTOPERATIVE CARE; POSTOPERATIVE PAIN; PRIORITY JOURNAL; QUALITY OF LIFE; RADIUS FRACTURE; REHABILITATION CARE; REVIEW; RISK REDUCTION; SECONDARY PREVENTION; SPINE FRACTURE; VERTEBRA FRACTURE; VITAMIN SUPPLEMENTATION;

EID: 84856642007     PISSN: 17584272     EISSN: 17584280     Source Type: Journal    
DOI: 10.2217/ijr.11.68     Document Type: Review

References (129)

1. Dreinhofer KE, Feron JM, Herrerra A et al. Orthopaedic surgeons and fragility fractures. A survey by the bone and joint decade and the international osteoporosis foundation. J. Bone Joint Surg. Br. 86, 958-961 (2004).
2. WHO. Guidelines for preclinical evaluation and clinical trials in osteoporosis. WHO, Geneva, Switzerland (1998).
3. Sweet MG, Sweet JM, Jeremiah MP, Galazka SS. Diagnosis and treatment of osteoporosis. Am. Fam. Physic. 79(3), 193-200 (2009).
4. Cummings SR, Melton LJ. Epidemiology and outcomes of osteoporotic fractures. Lancet 359 (9319), 1761-1767 (2002).
5. Johnell O, Kanis JA. An estimate of the worldwide prevalence and disability associated with osteoporotic fractures. Osteoporos. Int. 17(12), 1726-1733 (2006). (Pubitemid 44607392)
6. Lippuner K, Johansson H, Kanis JA, Rizzoli R. Remaining lifetime and absolute 10-year probabilities of osteoporotic fracture in Swiss men and women. Osteoporos. Int. 20(7), 1131-1140 (2009).
7. National Osteoporosis Foundation. Clinician's Guide to the Prevention and Treatment of Osteoporosis. National Osteoporosis Foundation, Washington, DC, USA (2008).
8. British orthopaedic association. The care of the patient with fragility fracture. BOA-BGS, London, UK (2007).
9. Abrahamsen B, van Staa T, Ariely R, Olson M, Cooper C. Excess mortality following hip fracture: a systematic epidemiological review. Osteoporos. Int. 20(10), 1633-1650 (2009).
10. Lips P, van Schoor NM. Quality of life in patients with osteoporosis. Osteoporos. Int. 16(5), 447-455 (2005).
11. Cranney A, Guyatt G, Griffith L et al. Meta-analyses of therapies for postmenopausal osteoporosis. IX: summary of meta-analyses of therapies for postmenopausal osteoporosis. Endocr. Rev. 23(4), 570-578 (2002). (Pubitemid 34925651)
12. Ekman EF. The role of the orthopaedic surgeon in minimizing mortality and morbidity associated with fragility fractures. J. Am. Acad. Orthop. Surg. 18(5), 278-285 (2010).
13. Giannoudis PV, Schneider E. Principles of fixation of osteoporotic fractures. J. Bone Joint Surg. Br. 88(10), 1272-1278 (2006). (Pubitemid 44636844)
14. Magu NK, Singh R, Mittal R et al. Osteosynthesis and primary valgus intertrochanteric osteotomy in displaced intracapsular fracture neck of femur with osteoporosis in adults. Injury 36, 110-122 (2005). (Pubitemid 39611317)
15. Tejwani NC, Guerado E. Improving fixation of the osteoporotic fracture: the role of locked plating. J. Orthop. Trauma. 25(Suppl. 1), S56-S60 (2011).
16. Bottlang M, Doornink J, Byrd GD, Fitzpatrick DC, Madey SM. A nonlocking end screw can decrease fracture risk caused by locked plating in the osteoporotic diaphysis. J. Bone Joint Surg. Am. 91(3), 620-627 (2009).
17. Doornink J, Fitzpatrick DC, Boldhaus S, Madey SM, Bottlang M. Effects of hybrid plating with locked and nonlocked screws on the strength of locked plating constructs in the osteoporotic diaphysis. J. Trauma. 69(2), 411-417 (2010).
18. Moroni A, Faldini C, Pegreffi F, Giannini S. HA-coated screws decrease the incidence of fixation failure in osteoporotic trochanteric fractures. Clin. Orthop. Relat. Res. 425, 87-92 (2004). (Pubitemid 39062754)
19. Peter B, Pioletti DP, Laïb S et al. Calcium phosphate drug delivery system: influence of local zoledronate release on bone implant osteointegration. Bone 36(1), 52-60 (2005). (Pubitemid 40128274)
20. Raschke MJ, Schmidmaier G. Biological coating of implants in trauma and orthopedic surgery. Unfallchirurg 107(8), 653-663 (2004). (Pubitemid 39237166)
21. Haentjens P, Lamraski G. Endoprosthetic replacement of unstable, comminuted intertrochanteric fracture of the femur in the elderly, osteoporotic patient: a review. Disabil. Rehabil. 27(18-19), 1167-1180 (2005). (Pubitemid 41699889)
22. Parker MJ, Handoll HH. Replacement arthroplasty versus internal fixation for extracapsular hip fractures in adults. Cochrane Database Syst. Rev. 2, CD000086 (2006).
23. Vermeire J, Scheerlinck T. Early primary total knee replacement for complex proximal tibia fractures in elderly and osteoarthritic patients. Acta Orthop. Belg. 76(6), 785-793 (2010).
24. Chalidis B, Dimitriou C, Papadopoulos P, Petsatodis G, Giannoudis PV. Total elbow arthroplasty for the treatment of insufficient distal humeral fractures. A retrospective clinical study and review of the literature. Injury 40(6), 582-590 (2009).
25. Den Hartog D, Van Lieshout EM, Tuinebreijer WE et al. Primary hemiarthroplasty versus conservative treatment for comminuted fractures of the proximal humerus in the elderly (ProCon): a multicenter randomized controlled trial. BMC Musculoskelet. Disord. 11, 97 (2010).
26. Bogoch ER, Elliot-Gibson V, Beaton DE, Jamal SA, Josse RG, Murray TM. Effective initiation of osteoporosis diagnosis and treatment for patients with a fragility fracture in an orthopaedic environment. J. Bone Joint Surg. Am. 88(1), 25-34 (2006). (Pubitemid 43062769)
27. Ward SE, Laughren JJ, Escott BG, Elliot-Gibson V, Bogoch ER, Beaton DE. A program with a dedicated coordinator improved chart documentation of osteoporosis after fragility fracture. Osteoporos. Int. 18(8), 1127-1136 (2007). (Pubitemid 47019999)
28. Sander B, Elliot-Gibson V, Beaton DE, Bogoch ER, Maetzel A. A coordinator program in post-fracture osteoporosis management improves outcomes and saves costs. J. Bone Joint Surg. Am. 90(6), 1197-1205 (2008). (Pubitemid 351778125)
29. Piziak VK, Rajab MH. An effective team approach to improve postoperative hip fracture care. J. Orthop. Trauma. 25(2), 72-75 (2011).
30. Elliot-Gibson V, Bogoch ER, Jamal SA, Beaton DE. Practice patterns in the diagnosis and treatment of osteoporosis after a fragility fracture: a systematic review. Osteoporos. Int. 15(10), 767-778 (2004). (Pubitemid 39361946)
31. McLellan AR, Gallacher SJ, Fraser M, McQuillian C. The fracture liaison service: success of a program for the evaluation and management of patients with osteoporotic fracture. Osteoporos. Int. 14(12), 1028-1034 (2003). (Pubitemid 40824270)
32. Bouxsein ML, Kaufman J, Tosi L, Cummings S, Lane J, Johnell O. Recommendations for optimal care of the fragility fracture patient to reduce the risk of future fracture. J. Am. Acad. Orthop. Surg. 12(6), 385-395 (2004).
33. Javid KS, Thien A, Hill R. Implementation of and compliance with NICE guidelines in the secondary prevention of osteoporotic fractures in postmenopausal women. Ann. R. Coll. Surg. Engl. 90(3), 213-215 (2008). (Pubitemid 351593719)
34. Siris ES. Patients with hip fracture: what can be improved? Bone 38(2 Suppl. 2), S8-S12 (2006). (Pubitemid 43177166)
35. Rietbrock S, Olson M, van Staa TP. The potential effects on fracture outcomes of improvements in persistence and compliance with bisphosphonates. QJM 102(1), 35-42 (2009).
36. NICE. Alendronate, etidronate, reisedronate, raloxifene, strontium, ranelate and teriparatide for the secondary prevention of osteoporotic fragility fractures in postmenopausal women. London, UK (2008).
37. Lyles KW, Colon-Emeric CS, Magaziner JS et al. Zoledronic acid and clinical fractures and mortality after hip fracture. N. Engl. J. Med. 357, 1799-1809 (2007). (Pubitemid 350044800)
38. Isaacs JD, Shidiak L, Harris IA, Szomor ZL. Femoral insufficiency fractures associated with prolonged bisphosphonate therapy. Clin. Orthop. Relat. Res. 468(12), 3384-3392 (2010).
39. Charopoulos I, Orme S, Giannoudis PV. Fracture risk associated with chronic use of bisphosphonates: evidence today. Exp. Opin. Drug Saf. 10(1), 67-76 (2011).
40. Kim SY, Schneeweiss S, Katz JN, Levin R, Solomon DH. Oral bisphosphonates and risk of subtrochanteric or diaphyseal femur fractures in a population-based cohort. J. Bone Miner. Res. 26(5), 993-1001 (2011).
41. Sellmeyer DE. Atypical fractures as a potential complication of long-term bisphosphonate therapy. JAMA 304(13), 1480-1484 (2010).
42. Hopkins RB, Goeree R, Pullenayegum E et al. The relative efficacy of nine osteoporosis medications for reducing the rate of fractures in post-menopausal women. BMC Musculoskelet. Disord. 12, 209 (2011).
43. Papaionnou A, Morin S, Cheung AM et al. 2010 clinical practice guidelines for the diagnosis and management of osteoporosis in Canada: summary. CMAJ 182, 1864-1873 (2010).
44. Knopp JA, Diner BM, Blitz M et al. Calcitonin for treating acute pain of osteoporotic vertebral compression fractures: a systematic review of randomized, controlled trials. Osteoporos. Int. 16, 1281-1290 (2005). (Pubitemid 41396958)
45. Langdahl BL, Rajzbaum G, Jakob F et al. Reduction in fracture rate and back pain and increased quality of life in postmenopausal women treated with teriparatide: 18-month data from the European forsteo observational study (EFOS). Calcif. Tissue Int. 85, 484-493 (2009).
46. Reginster JY. Antifracture efficacy of currently available therapies for postmenopausal osteoporosis. Drugs 71(1), 65-78 (2011).
47. Jansen JP, Bergman GJ, Huels J, Olson M. The efficacy of bisphosphonates in the prevention of vertebral, hip, and nonvertebral-nonhip fractures in osteoporosis: a network meta-analysis. Semin. Arthrit. Rheum. 40(4), 275-284 (2011).
48. Black DM, Delmas PD, Eastell R et al. HORIZON pivotal fracture trial. Once-yearly zoledronic acid for treatment of postmenopausal osteoporosis. N. Engl. J. Med. 356, 1809-1822 (2007). (Pubitemid 46698462)
49. Chesnut CH 3rd, Skag A, Christiansen C et al. Oral Ibandronate Osteoporosis Vertebral Fracture Trial in North America and Europe (BONE). Effects of oral ibandronate administered daily or intermittently on fracture risk in postmenopausal osteoporosis. J. Bone Miner. Res. 19, 1241-1249 (2004). (Pubitemid 41094364)
50. Petrella RJ, Jones TJ. Do patients receive recommended treatment of osteoporosis following hip fracture in primary care? BMC Fam. Pract. 7, 31 (2006).
51. Seeman E, Compston J, Adachi J et al. Non-compliance: the Achilles' heel of anti-fracture efficacy. Osteoporos. Int. 18, 711-719 (2007). (Pubitemid 46684777)
52. Reginster JY. Adherence and persistence: impact on outcomes and health care resources. Bone 38(2 Suppl. 2), S18-S21 (2006).
53. Adachi JD, Josse RG, Russell RG. If you don't take it -it can't work: the consequences of not being treated or nonadherence to osteoporosis therapy. Ther. Clin. Risk Manag. 7, 181-198 (2011).
54. Zhang J, Saag KG, Curtis JR. Long-term safety concerns of antiresorptive therapy. Rheum. Dis. Clin. N. Am. 37(3), 387-400 (2011).
55. Clowes JA, Peel NF, Eastell R. The impact of monitoring on adherence and persistence with antiresorptive treatment for postmenopausal osteoporosis: a randomized controlled trial. J. Clin. Endocrinol. Metab. 89(3), 1117-1123 (2004). (Pubitemid 38368399)
56. Miller PD. Denosumab: anti-RANKL antibody. Curr. Osteoporos. Rep. 7(1), 18-22 (2009).
57. Moen MD, Keam SJ. Denosumab: a review of its use in the treatment of postmenopausal osteoporosis. Drugs Aging 28(1), 63-82 (2011).
58. Scotland G, Waugh N, Royle P, McNamee P, Henderson R, Hollick R. Denosumab for the prevention of osteoporotic fractures in post-menopausal women: a NICE single technology appraisal. Pharmacoeconomics 29(11), 951-961 (2011).
59. Giammattei F, Giammattei J, Howland V. Physician follow-up care for osteoporosis after fragility fractures. Phys. Sportsmed. 37(4), 62-67 (2009).
60. Lüthje P, Nurmi-Lüthje I, Kaukonen JP, Kuurne S, Naboulsi H, Kataja M. Undertreatment of osteoporosis following hip fracture in the elderly. Arch. Gerontol. Geriatr. 49(1), 153-157 (2009).
61. Cashman KD. Diet, nutrition, and bone health. J. Nutr. 137(Suppl. 11), S2507-S2512 (2007).
62. Warensjö E, Byberg L, Melhus H et al. Dietary calcium intake and risk of fracture and osteoporosis: prospective longitudinal cohort study. BMJ 342, 1473 (2011).
63. Tang BM, Eslick GD, Nowson C et al. Use of calcium or calcium in combination with vitamin D supplementation to prevent fractures and bone loss in people aged 50 years and older: a meta-analysis. Lancet 370, 657-666 (2007). (Pubitemid 47285316)
64. Bolland MJ, Avenell A, Baron JA et al. Effect of calcium supplements on risk of myocardial infarction and cardiovascular events: meta-analysis. BMJ 341, c3691 (2010).
65. Nurmi-Lüthje I, Lüthje P, Kaukonen JP et al. Post-fracture prescribed calcium and vitamin D supplements alone or, in females, with concomitant anti-osteoporotic drugs is associated with lower mortality in elderly hip fracture patients: a prospective analysis. Drugs Aging 26(5), 409-421 (2009).
66. Murad MH, Elamin KB, Abu Elnour NO et al. The effect of vitamin D on falls: a systematic review and meta-analysis. J. Clin. Endocrinol. Metab. 96(10), 2997-3006 (2011).
67. Bischoff-Ferrari HA, Willett WC, Wong JB, Giovannucci E, Dietrich T, Dawson-Hughes B. Fracture prevention with vitamin D supplementation: a meta-analysis of randomized controlled trials. JAMA 293(18), 2257-2264 (2005). (Pubitemid 40629192)
68. Bolland MJ, Barber PA, Doughty RN et al. Vascular events in healthy older women receiving calcium supplementation: randomised controlled trial. BMJ 336(7638), 262-266 (2008). (Pubitemid 351251627)
69. Bolland MJ, Grey A, Avenell A, Gamble GD, Reid IR. Calcium supplements with or without vitamin D and risk of cardiovascular events: reanalysis of the Women's Health Initiative limited access dataset and meta-analysis. BMJ 342, d2040 (2011).
70. Martyn-St James M, Carroll S. High-intensity resistance training and postmenopausal bone loss: a meta-analysis. Osteoporos. Int. 17(8), 1225-1240 (2006).
71. Naunton M, Peterson GM, Jones G, Griffin GM, Bleasel MD. Multifaceted educational program increases prescribing of preventive medication for corticosteroid induced osteoporosis. J. Rheumatol. 31(3), 550-556 (2004). (Pubitemid 38337618)
72. Bours SP, van Geel TA, Geusens PP et al. Contributors to secondary osteoporosis and metabolic bone diseases in patients presenting with a clinical fracture. J. Clin. Endocrinol. Metab. 96(5), 1360-1367 (2011).
73. Klotzbuecher CM, Ross PD, Landsman PB, Abbott TA 3rd, Berger M. Patients with prior fractures have an increased risk of future fractures: a summary of the literature and statistical synthesis. J. Bone Miner. Res. 15, 721-739 (2000). (Pubitemid 30174026)
74. Gillespie LD, Robertson MC, Gillespie WJ et al. Interventions for preventing falls in older people living in the community. Cochrane Database Syst. Rev. 2, CD007146 (2009).
75. Cameron ID, Murray GR, Gillespie LD et al. Interventions for preventing falls in older people in nursing care facilities and hospitals. Cochrane Database Syst. Rev. 1, CD005465 (2010).
76. Dharmarajan TS, Banik P. Hip fracture: risk factors, preoperative assessment, and postoperative management. Postgrad. Med. 119, 31-38 (2006).
77. Novack V, Jotkowitz A, Etzion O, Porath A. Does delay in surgery after hip fracture lead to worse outcomes? A multicenter survey. Int. J. Qual. Health Care 19, 170-176 (2007). (Pubitemid 47090641)
78. Paksima N, Koval KJ, Aharanoff G et al. Predictors of mortality after hip fracture: a 10-year prospective study. Bull. NYU Hosp. Jt Dis. 66, 111-117 (2008). (Pubitemid 351898375)
79. von Friesendorff M, Besjakov J, Akesson K. Long-term survival and fracture risk after hip fracture: a 22-year follow-up in women. J. Bone Miner. Res. 23, 1832-1841 (2008).
80. Kannegaard PN, van der Mark S, Eiken P, Abrahamsen B. Excess mortality in men compared with women following a hip fracture. National analysis of comedications, comorbidity and survival. Age Ageing 39(2), 203-209 (2010).
81. Schrøder HM, Petersen KK, Erlandsen M. Occurrence and incidence of the second hip fracture. Clin. Orthop. Relat. Res. 289, 166-169 (1993). (Pubitemid 23124805)
82. Berry SD, Samelson EJ, Hannan MT et al. Second hip fracture in older men and women: the Framingham Study. Arch. Intern. Med. 167(18), 1971-1976 (2007). (Pubitemid 47606637)
83. Nymark T, Lauritsen JM, Ovesen O, Röck ND, Jeune B. Short time-frame from first to second hip fracture in the Funen county hip fracture study. Osteoporos. Int. 17(9), 1353-1357 (2006). (Pubitemid 44127322)
84. Kaukonen JP, Lüthje P, Nurmi-Lüthje I, Kataja M, Naboulsi H. Second hip fracture and patients' medication after the first hip fracture: a follow-up of 221 hip fracture patients in Finland. Arch. Gerontol. Geriatr. 52(2), 185-189 (2011).
85. Majumdar SR, Beaupre LA, Johnston DW, Dick DA, Cinats JG, Jiang HX. Lack of association between mortality and timing of surgical fixation in elderly patients with hip fracture: results of a retrospective population-based cohort study. Med. Care 44(6), 552-559 (2006). (Pubitemid 44303958)
86. Orosz GM, Magaziner J, Hanna EL et al. Association of timing of surgery for hip fracture and patient outcomes. JAMA 291, 1738-1743 (2004). (Pubitemid 38489896)
87. Shiga T, Wajima Z, Ohe Y. Is operative delay associated with increased mortality of hip fracture patients? Systematic review, meta-analysis, and meta-regression. Can. J. Anaesth. 55(3), 146-154 (2008). (Pubitemid 351449431)
88. Vidán MT, Sánchez E, Gracia Y, Maran E, Vaquero J, Serra JA. Causes and effects of surgical delay in patients with hip fracture: a cohort study. Ann. Intern. Med. 155(4), 226-233 (2011).
89. Moran CG, Wenn RT, Sikand M, Taylor AM. Early mortality after hip fracture: is delay before surgery important? J. Bone Joint Surg. Am. 87(3), 483-489 (2005). (Pubitemid 40314995)
90. Rodriguez-Fernandez P, Adarraga-Cansino D, Carpintero P. Effects of delayed hip fracture surgery on mortality and morbidity in elderly patients. Clin. Orthop. Relat. Res. 469(11), 3218-3221 (2011).
91. Al-Ani AN, Samuelsson B, Tidermark J et al. Early operation on patients with a hip fracture improved the ability to return to independent living. A prospective study of 850 patients. J. Bone Joint Surg. Am. 90(7), 1436-1442 (2008). (Pubitemid 351947583)
92. Morrison RS, Siu AL. A comparison of pain and its treatment in advanced dementia and cognitively intact patients with hip fracture. J. Pain Symptom Manage. 19, 240-248 (2000). (Pubitemid 30224690)
93. Shyu YI, Chen ML, Chen MC, Wu CC, Su JY. Postoperative pain and its impact on quality of life for hip-fractured older people over 12 months after hospital discharge. J. Clin. Nurs. 18(5), 755-764 (2009).
94. Abou-Setta AM, Beaupre LA, Rashiq S et al. Comparative effectiveness of pain management interventions for hip fracture: a systematic review. Ann. Intern. Med. 155(4), 234-245 (2011).
95. Björkelund KB, Hommel A, Thorngren KG, Gustafson L, Larsson S, Lundberg D. Reducing delirium in elderly patients with hip fracture: a multi-factorial intervention study. Acta Anaesthesiol. Scand. 54(6), 678-688 (2010).
96. Nie H, Zhao B, Zhang YQ, Jiang YH, Yang YX. Pain and cognitive dysfunction are the risk factors of delirium in elderly hip fracture Chinese patients. Arch. Gerontol. Geriatr. doi:10.1016/j.archger.2011.09.012 (2011) (Epub ahead of print).
97. Friedman SM, Mendelson DA, Bingham KW, Kates SL. Impact of a comanaged geriatric fracture center on short-term hip fracture outcomes. Arch. Intern. Med. 169(18), 1712-1717 (2009).
98. Heyburn G, Beringer T, Elliott J, Marsh D. Orthogeriatric care in patients with fractures of the proximal femur. Clin. Orthop. Relat. Res. 425, 35-43 (2004). (Pubitemid 39062747)
99. Kammerlander C, Roth T, Friedman SM et al. Ortho-geriatric service -a literature review comparing different models. Osteoporos. Int. 21(Suppl. 4), S637-S646 (2010).
100. Gehlbach SH, Bigelow C, Heimisdottir M, May S, Walker M, Kirkwood JR. Recognition of vertebral fracture in a clinical setting. Osteoporos. Int. 11, 577-582 (2000).
101. The European Prospective Osteoporosis Study Group: incidence of vertebral fracture in Europe: results from the European Prospective Osteoporosis Study (EPOS). J. Bone Miner. Res. 17, 716-724 (2002).
102. Kim DH, Vaccaro AR. Osteoporotic compression fractures of the spine; current options and considerations for treatment. Spine J. 6(5), 479-487 (2006).
103. Esses SI, McGuire R, Jenkins J et al. The treatment of symptomatic osteoporotic spinal compression fractures. J. Am. Acad. Orthop. Surg. 19(3), 176-182 (2011).
104. Melton LJ 3rd. Adverse outcomes of osteoporotic fractures in the general population. J. Bone Miner. Res. 18, 1139-1141 (2003).
105. Haentjens P, Autier P, Collins J, Velkeniers B, Vanderschueren D, Boonen S. Colles fracture, spine fracture, and subsequent risk of hip fracture in men and women. A meta-analysis. J. Bone Joint Surg. Am. 85(10), 1936-1943 (2003). (Pubitemid 37259729)
106. Hodsman AB, Leslie WD, Tsang JF, Gamble GD. 10-year probability of recurrent fractures following wrist and other osteoporotic fractures in a large clinical cohort: an analysis from the Manitoba bone density program. Arch. Intern. Med. 168(20), 2261-2267 (2008).
107. Lichtman DM, Bindra RR, Boyer MI et al. Treatment of distal radius fractures. J. Am. Acad. Orthop. Surg. 18(3), 180-189 (2010).
108. Kannus P, Palvanen M, Niemi S, Parkkari J, Järvinen M. Epidemiology of osteoporotic pelvic fractures in elderly people in Finland: sharp increase in 1970-1997 and alarming projections for the new millennium. Osteoporos. Int. 11(5), 443-448 (2000). (Pubitemid 30450128)
109. Breuil V, Roux CH, Testa J et al. Outcome of osteoporotic pelvic fractures: an underestimated severity. Survey of 60 cases. Joint Bone Spine 75(5), 585-588 (2008).
110. Krappinger D, Kammerlander C, Hak DJ, Blauth M. Low-energy osteoporotic pelvic fractures. Arch. Orthop. Trauma. Surg. 130(9), 1167-1175 (2010).
111. Culemann U, Scola A, Tosounidis G, Pohlemann T, Gebhard F. Concept for treatment of pelvic ring injuries in elderly patients. A challenge. Unfallchirurg 113(4), 258-271 (2010).
112. Cornell CN. Management of acetabular fractures in the elderly patient. HSS J. 1(1), 25-30 (2005).
113. Switzer JA, Jaglal S, Bogoch ER. Overcoming barriers to osteoporosis care in vulnerable elderly patients with hip fractures. J. Orthop. Trauma. 23(6), 454-459 (2009).
114. Orwig DL, Hochberg M, Yu-Yahiro J et al. Delivery and outcomes of a yearlong home exercise program after hip fracture: a randomized controlled trial. Arch. Intern. Med. 171(4), 323-331 (2011).
115. Handoll HH, Sherrington C, Parker MJ. Mobilisation strategies after hip fracture surgery in adults. Cochrane Database Syst. Rev. 4, CD001704 (2004).
116. Crotty M, Unroe K, Cameron ID, Miller M, Ramirez G, Couzner L. Rehabilitation interventions for improving physical and psychosocial functioning after hip fracture in older people. Cochrane Database Syst. Rev. 1, CD007624 (2010).
117. Handoll HH, Cameron ID, Mak JC, Finnegan TP. Multidisciplinary rehabilitation for older people with hip fractures. Cochrane Database Syst. Rev. 4, CD007125 (2009).
118. Handoll HH, Madhok R, Howe TE. Rehabilitation for distal radial fractures in adults. Cochrane Database Syst. Rev. 3, CD003324 (2006).
119. Boonen S, Autier P, Barette M, Vanderschueren D, Lips P, Haentjens P. Functional outcome and quality of life following hip fracture in elderly women: a prospective controlled study. Osteoporos. Int. 15(2), 87-94 (2004). (Pubitemid 38252421)
120. Silverman S, Viswanathan HN, Yang YC et al. Impact of clinical fractures on health-related quality of life is dependent on time of assessment since fracture: results from the FREEDOM trial. Osteoporos. Int. doi:10.1007/s00198- 011-1720-0 (2011) (Epub ahead of print).
121. Herrick C, Steger-May K, Sinacore DR, Brown M, Schechtman KB, Binder EF. Persistent pain in frail older adults after hip fracture repair. J. Am. Geriatr. Soc. 52, 2062-2068 (2004). (Pubitemid 41725024)
122. Morrison RS, Magaziner J, McLaughlin MA et al. The impact of post-operative pain on outcomes following hip fracture. Pain 103, 303-311 (2003). (Pubitemid 36638818)
123. Rachner TD, Khosla S, Hofbauer LC. Osteoporosis: now and the future. Lancet 377(9773), 1276-1287 (2011).
124. Ralston SH. Genetics of osteoporosis. Ann. NY Acad. Sci. 1192, 81-189 (2010).
125. Jaglal SB, Cameron C, Hawker GA et al. Development of an integrated-care delivery model for post-fracture care in Ontario, Canada. Osteoporos. Int. 17(9), 1337-1345 (2006). (Pubitemid 44127320)
126. American academy of orthopaedic surgeons clinical guideline. Rating scheme for the strength of the recommendations. www.guideline.gov/content.aspx? id=10850
127. Duff G. Further advice on safety of HRT. Risk: benefit unfavourable for first-line use in prevention of osteoporosis (Committee on Safety of Medicines) (2003). www.mhra.gov.uk/home/groups/pl-p/documents/websiteresources/con019496. pdf
128. Canadian agency for drugs and technologies in health, health technology: policy guidance on hip protectors in long-term care, Canada (2010). www.cadth.ca/en/products/optimal-use/policy-guid-hip-protect
129. Michael YL, Lin JS, Whitlock EP et al. Interventions to prevent falls in older adults: an updated systematic review [Internet]. Rockville (MD): Agency for healthcare research and quality (US) (2010). www.ncbi.nlm.nih.gov/books/ NBK51685